In the interests of safe medication use, I strongly disagree with the recommendations expressed in the article by Schwab et al1 that appeared in the May 13, 2002, issue of the ARCHIVES. It is an overstatement to condemn trade names as impediments to the safe use of pharmaceutical products. Yes, there are certainly instances when trade names have been associated with medication errors, but there are also instances when INNs have been associated with medication errors. Eliminating, or even limiting the use of trade names in an unreasonable manner could put patients at an unacceptable risk of medication errors.
Cohen MR. Trade Name, INNs, and Medication Errors. Arch Intern Med. 2002;162(22):2636. doi: